Evaluation of the use of apixaban in prevention of thromboembolic disease in patients with myeloma treated with iMiDs

被引：0
|
作者：
Gavard, M. [1 ]
Pegourie, B. [2 ]
Pernod, G. [3 ]
Rolland-Neyret, V. [2 ]
机构：
[1] CHU Grenoble Alpes, Delegat Rech Clin & Innovat, Grenoble, France
[2] CHU Grenoble Alpes, Serv Hematol, Grenoble, France
[3] CHU Grenoble Alpes, Serv Med Vasc, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2 - 044
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy
    Cornell, Robert Frank
    Goldhaber, Samuel Z.
    Engelhardt, Brian G.
    Moslehi, Javid
    Jagasia, Madan
    Patton, Daryl
    Harrell, Shelton Lacy
    Hall, Robert L.
    Wyatt, Houston
    Piazza, Gregory
    BLOOD, 2018, 132
  • [32] Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Garcia, David A.
    Fisher, Deborah A.
    Mulder, Hillary
    Wruck, Lisa
    De Caterina, Raffele
    Halvorsen, Sigrun
    Granger, Christopher B.
    Held, Claes
    Wallentin, Lars
    Alexander, John H.
    Lopes, Renato D.
    AMERICAN HEART JOURNAL, 2020, 221 : 1 - 8
  • [33] Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease
    VanderPluym, Christina
    Esteso, Paul
    Ankola, Ashish
    Hellinger, Amy
    Ventresco, Courtney
    Hawkins, Beth
    Kobayashi, Ryan L.
    Williams, Ryan
    Cetatoiu, Maria A.
    Gauvreau, Kimberlee
    Esch, Jesse J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (08) : 1601 - 1609
  • [34] Use of Daratumumab in Patients With Previously Treated Multiple Myeloma
    Patel, Ashwin P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14)
  • [35] Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)
    Patel, Jai N.
    Jagosky, Megan Helena
    Robinson, Myra M.
    Slaughter, Daniel
    Arnall, Justin
    Matusz-Fisher, Ashley
    Bhutani, Manisha
    Voorhees, Peter M.
    Usmani, Saad Z.
    BLOOD, 2018, 132
  • [36] Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens
    Storrar, Neill P. F.
    Mathur, Abhinav
    Johnson, Peter R. E.
    Roddie, P. Huw
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 142 - 144
  • [37] BISHYDROXYCOUMARIN (DICUMAROL) PROPHYLAXIS - USE IN THE PREVENTION OF POSTOPERATIVE THROMBOEMBOLIC COMPLICATIONS IN SURGICAL PATIENTS
    MILCH, E
    BERMAN, L
    EGAN, RW
    ARCHIVES OF SURGERY, 1961, 83 (03) : 444 - 447
  • [38] AN EVALUATION OF SULOCTIDIL IN THE SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS SURVIVING A THROMBOEMBOLIC STROKE
    GENT, M
    STROKE, 1984, 15 (01) : 197 - 197
  • [39] EVALUATION OF THE EFFICACY OF APIXABAN USE FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH CIRRHOSIS
    Walker, Christopher
    Aljudaibi, Bandar
    Martens, John
    Laryea, Marie
    Ramaraju, Gopal A.
    Levstik, Mark A.
    Melaragno, Jennifer
    HEPATOLOGY, 2019, 70 : 265A - 265A
  • [40] VALUE OF MONITORING HEPARIN THERAPY IN PREVENTION OF RECURRENCE IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE
    HIRSH, J
    THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1973, : 181 - 190
12345